ZNF283 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.678200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.790000E-01
Normal-vs-Stage2
5.210000E-01
Normal-vs-Stage3
4.118100E-02
Normal-vs-Stage4
8.503200E-01
Stage1-vs-Stage2
3.524800E-01
Stage1-vs-Stage3
5.748100E-02
Stage1-vs-Stage4
8.898200E-01
Stage2-vs-Stage3
1.753370E-01
Stage2-vs-Stage4
3.655400E-01
Stage3-vs-Stage4
4.973600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.824600E-01
Normal-vs-AfricanAmerican
6.247200E-01
Normal-vs-Asian
2.444200E-01
Caucasian-vs-AfricanAmerican
7.004400E-01
Caucasian-vs-Asian
4.863600E-01
AfricanAmerican-vs-Asian
3.886800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.188400E-01
Normal-vs-Female
5.372200E-01
Male-vs-Female
7.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.968200E-01
Normal-vs-Age(41-60Yrs)
8.315400E-01
Normal-vs-Age(61-80Yrs)
2.829200E-01
Normal-vs-Age(81-100Yrs)
1.755430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.973400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.815300E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.474100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.372300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.401230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.830800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.745000E-01
Normal-vs-Daily Drinker
2.510800E-01
Normal-vs-Weekly Drinker
4.807400E-01
Normal-vs-Occasional Drinker
8.573600E-01
Normal-vs-Social Drinker
5.624000E-01
Non Drinker-vs-Daily Drinker
6.474800E-01
Non Drinker-vs-Weekly Drinker
3.518600E-01
Non Drinker-vs-Occasional Drinker
3.826000E-02
Non Drinker-vs-Social Drinker
3.270200E-01
Daily Drinker-vs-Weekly Drinker
5.969400E-01
Daily Drinker-vs-Occasional Drinker
1.125000E-01
Daily Drinker-vs-Social Drinker
5.607200E-01
Weekly Drinker-vs-Occasional Drinker
3.868200E-01
Weekly Drinker-vs-Social Drinker
9.473600E-01
Occasional Drinker-vs-Social Drinker
4.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.332000E-02
Normal-vs-Grade 2
2.288300E-02
Normal-vs-Grade 3
7.198200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.153500E-02
Grade 1-vs-Grade 3
4.821000E-03
Grade 1-vs-Grade 4
5.332000E-02
Grade 2-vs-Grade 3
5.343600E-01
Grade 2-vs-Grade 4
2.288300E-02
Grade 3-vs-Grade 4
7.198200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.242620E-01
Normal-vs-NonDiabetic
3.963800E-01
Diabetic-vs-NonDiabetic
1.844360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.091400E-01
Normal-vs-NoPancreatitis
3.382400E-01
Pancreatitis-vs-NoPancreatitis
7.457600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.099200E-01
Normal-vs-N1
4.531400E-01
N0-vs-N1
8.108000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.316600E-01
Normal-vs-TP53-NonMutant
6.945600E-01
TP53-Mutant-vs-TP53-NonMutant
1.232400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
